Profile
Sector:
HealthcareIndustry:
Medical DevicesCountry:
United StatesIPO:
15 July 2021Website:
http://www.rapidmicrobio.comNext earnings report:
28 February 2025Last dividends:
N/ANext dividends:
N/APrice
after hours | Thu, 14 Nov 2024 23:24:42 GMTDividend
Analysts recommendations
Institutional Ownership
RPID Latest News
LEXINGTON, Mass., Nov. 08, 2024 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, today announced that the Company will participate in the Stifel 2024 Healthcare Conference.
Rapid Micro Biosystems, Inc. (RPID) came out with a quarterly loss of $0.26 per share in line with the Zacks Consensus Estimate. This compares to loss of $0.31 per share a year ago.
LEXINGTON, Mass., Oct. 23, 2024 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission-critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, will release third quarter 2024 financial results prior to the market open on Friday, November 1, 2024.
LOWELL, Mass., July 17, 2024 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission-critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, will release second quarter 2024 financial results prior to the market open on Friday, August 2, 2024.
Rapid Micro Biosystems, Inc. (RPID) reported a quarterly loss of $0.31 per share, slightly higher than the Zacks Consensus Estimate of $0.29 per share but an improvement from the loss of $0.32 per share in the same quarter last year.
Rapid Micro Biosystems, Inc. (RPID) Q4 2023 Earnings Call Transcript
LOWELL, Mass., Feb. 20, 2024 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission-critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, will release fourth quarter and full year 2023 financial results prior to the market open on Friday, March 1, 2024.
LOWELL, Mass., Jan. 03, 2024 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, today announced that the Company will participate in the 42nd Annual J.P. Morgan Healthcare Conference.
LOWELL, Mass., Nov. 07, 2023 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, today announced that the Company will participate in the following investor conferences in New York, NY:
Rapid Micro Biosystems, Inc. (RPID) came out with a quarterly loss of $0.31 per share versus the Zacks Consensus Estimate of a loss of $0.32. This compares to loss of $0.38 per share a year ago.
What type of business is Rapid Micro Biosystems?
Rapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in the United States, Germany, Switzerland, Japan, and internationally. The company offers Growth Direct platform, which includes Growth Direct system, proprietary consumables, lab information management system connection software, and customer support and validation services. Its platform automates and modernizes the manual microbial quality control (MQC) testing workflows for therapeutic modalities, such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company also provides onsite technical training services. Its solutions are used in environmental monitoring, water, bioburden, and sterility release testing applications. In addition, the company offers RMBNucleus software for the Growth Direct system; RMBNucleus Mold Alarm signals at the first sign of mold detection; RMBNucleus Central Manager portal streamlines coordination of multiple instruments; and Growth Direct LIMS connection software. Rapid Micro Biosystems, Inc. was formerly known as Genomic Profiling Systems, Inc. and changed its name to Rapid Micro Biosystems, Inc. in January 2007. The company was incorporated in 2006 and is headquartered in Lowell, Massachusetts.
What sector is Rapid Micro Biosystems in?
Rapid Micro Biosystems is in the Healthcare sector
What industry is Rapid Micro Biosystems in?
Rapid Micro Biosystems is in the Medical Devices industry
What country is Rapid Micro Biosystems from?
Rapid Micro Biosystems is headquartered in United States
When did Rapid Micro Biosystems go public?
Rapid Micro Biosystems initial public offering (IPO) was on 15 July 2021
What is Rapid Micro Biosystems website?
https://www.rapidmicrobio.com
Is Rapid Micro Biosystems in the S&P 500?
No, Rapid Micro Biosystems is not included in the S&P 500 index
Is Rapid Micro Biosystems in the NASDAQ 100?
No, Rapid Micro Biosystems is not included in the NASDAQ 100 index
Is Rapid Micro Biosystems in the Dow Jones?
No, Rapid Micro Biosystems is not included in the Dow Jones index
When was Rapid Micro Biosystems the previous earnings report?
No data
When does Rapid Micro Biosystems earnings report?
The next expected earnings date for Rapid Micro Biosystems is 28 February 2025